Cargando…

Iranian general populations' and health care providers' preferences for benefits and harms of statin therapy for primary prevention of cardiovascular disease

BACKGROUND: The use of statins for primary prevention of cardiovascular diseases is associated with different benefit and harm outcomes. The aime of this study is how important these outcomes are for people and what people's preferences are. METHODS: We conducted a preference-eliciting survey i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saadati, Hassan, Baradaran, Hamid Reza, Danaei, Goodarz, Ostovar, Afshin, Hadaegh, Farzad, Janani, Leila, Steyerberg, Ewout W., Khalili, Davood
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7640674/ https://www.ncbi.nlm.nih.gov/pubmed/33148227 http://dx.doi.org/10.1186/s12911-020-01304-w

Ejemplares similares

The Trend of Risk for Cardiovascular Diseases During the Past Decade in Iran, Applying No-Lab and Lab-Based Prediction Models
por: Fahimfar, Noushin, et al.
Publicado: (2023)

Trends in cardiovascular risk factors in diabetic patients in comparison to general population in Iran: findings from National Surveys 2007–2016
por: Malekzadeh, Hamid, et al.
Publicado: (2020)

External validation of the American prediction model for incident type 2 diabetes in the Iranian population
por: Asgari, Samaneh, et al.
Publicado: (2023)

Letter to the Editor Regarding “Nationwide Prevalence of Diabetes and Prediabetes and Associated Risk Factors Among Iranian Adults: Analysis of Data from PERSIAN Cohort Study”
por: Asgari, Samaneh, et al.
Publicado: (2021)

Are the determinants of the progression to type 2 diabetes and regression to normoglycemia in the populations with pre-diabetes the same?
por: Alizadeh, Zeinab, et al.
Publicado: (2022)

Prehypertension Tsunami: A Decade Follow-Up of an Iranian Adult Population
por: Hadaegh, Farzad, et al.
Publicado: (2015)

Sudden cardiac death among Iranian population: a two decades follow-up of Tehran lipid and glucose study
por: Toreyhi, Hossein, et al.
Publicado: (2021)

Performance of Stepwise Screening Methods in Identifying Individuals at High Risk of Type 2 Diabetes in an Iranian Population
por: Lotfaliany, Mojtaba, et al.
Publicado: (2021)

Older adult preferences regarding benefits and harms of statin and aspirin therapy for cardiovascular primary prevention()
por: Wang, Frances M., et al.
Publicado: (2023)

National trends in cardiovascular health metrics among Iranian adults using results of three cross-sectional STEPwise approaches to surveillance surveys
por: Rahmani, Fatemeh, et al.
Publicado: (2021)

Should statin guidelines consider patient preferences? Eliciting preferences of benefit and harm outcomes of statins for primary prevention of cardiovascular disease in the sub-Saharan African and European contexts
por: Yebyo, Henock G., et al.
Publicado: (2018)

Multi-trajectories of lipid indices with incident cardiovascular disease, heart failure, and all-cause mortality: 23 years follow-up of two US cohort studies
por: Koohi, Fatemeh, et al.
Publicado: (2021)

Validation of the Framingham hypertension risk score in a middle eastern population: Tehran lipid and glucose study (TLGS)
por: Koohi, Fatemeh, et al.
Publicado: (2021)

Incidence of Chronic Kidney Disease and Its Risk Factors, Results of Over 10 Year Follow Up in an Iranian Cohort
por: Tohidi, Maryam, et al.
Publicado: (2012)

Prediction Models for Type 2 Diabetes Risk in the General Population: A Systematic Review of Observational Studies
por: Asgari, Samaneh, et al.
Publicado: (2021)

Trends of low physical activity among Iranian adolescents across urban and rural areas during 2006–2011
por: Amiri, Parisa, et al.
Publicado: (2020)

Divergent pathway of lipid profile components for cardiovascular disease and mortality events: Results of over a decade follow-up among Iranian population
por: Ghasemzadeh, Zahra, et al.
Publicado: (2016)

Statins and Risk of Diabetes: An analysis of electronic medical records to evaluate possible bias due to differential survival
por: Danaei, Goodarz, et al.
Publicado: (2013)

National trends of pre-hypertension and hypertension among Iranian adolescents across urban and rural areas (2007–2011)
por: Amiri, Parisa, et al.
Publicado: (2019)

Correction to: National trends of pre-hypertension and hypertension among Iranian adolescents across urban and rural areas (2007–2011)
por: Amiri, Parisa, et al.
Publicado: (2019)

"Predictability of body mass index for diabetes: Affected by the presence of metabolic syndrome?"
por: Hadaegh, Farzad, et al.
Publicado: (2011)

New and known type 2 diabetes as coronary heart disease equivalent: results from 7.6 year follow up in a middle east population
por: Hadaegh, Farzad, et al.
Publicado: (2010)

Risk factors for ischemic stroke; results from 9 years of follow-up in a population based cohort of Iran
por: Fahimfar, Noushin, et al.
Publicado: (2012)

Status of Hypertension in Tehran: Potential impact of the ACC/AHA 2017 and JNC7 Guidelines, 2012–2015
por: Asgari, Samaneh, et al.
Publicado: (2019)

External validation of the European risk assessment tool for chronic cardio-metabolic disorders in a Middle Eastern population
por: Asgari, Samaneh, et al.
Publicado: (2020)

Differences in the impact of impaired glucose status on clinical outcomes in younger and older adults: Over a decade of follow-up in the Tehran lipid and glucose study
por: Asgari, Samaneh, et al.
Publicado: (2022)

White rice intake and incidence of type-2 diabetes: analysis of two prospective cohort studies from Iran
por: Golozar, Asieh, et al.
Publicado: (2017)

The preferred IT sources and tools of Iranian people for accessing health information
por: Salmanizadeh, Farzad, et al.
Publicado: (2023)

Personalized Prediction of Lifetime Benefits with Statin Therapy for Asymptomatic Individuals: A Modeling Study
por: Ferket, Bart S., et al.
Publicado: (2012)

A new look at risk patterns related to coronary heart disease incidence using survival tree analysis: 12 Years Longitudinal Study
por: Ramezankhani, Azra, et al.
Publicado: (2017)

Metabolic syndrome in normal-weight Iranian adults
por: Hadaegh, Farzad, et al.
Publicado: (2007)

Anthropometric predictors of incident type 2 diabetes mellitus in Iranian women
por: Hadaegh, Farzad, et al.
Publicado: (2009)

Treatment gaps and potential cardiovascular risk reduction from expanded statin use in the US and England
por: Ueda, Peter, et al.
Publicado: (2018)

Adolescent lipoprotein classifications according to National Health and Nutrition Examination Survey (NHANES) vs. National Cholesterol Education Program (NCEP) for predicting abnormal lipid levels in adulthood in a Middle East population
por: Hatami, Masumeh, et al.
Publicado: (2012)

Twelve-Year Cardiovascular and Mortality Risk in Relation to Smoking Habits in Type 2 Diabetic and Non-Diabetic Men: Tehran Lipid and Glucose Study
por: Hadaegh, Farzad, et al.
Publicado: (2016)

Underestimating the Effect of Lipids on Cardiovascular Events: Regression Dilution Bias in the Population-Based Cohort of Tehran Lipid and Glucose Study
por: Masudi, Sima, et al.
Publicado: (2015)

Obesity Paradox and Recurrent Coronary Heart Disease in a Population-Based Study: Tehran Lipid and Glucose Study
por: Asgari, Samaneh, et al.
Publicado: (2016)

Anthropometric Indices as Predictors of Coronary Heart Disease Risk: Joint Modeling of Longitudinal Measurements and Time to Event
por: GILANI, Neda, et al.
Publicado: (2017)

Trajectories of cardiovascular disease risk and their association with the incidence of cardiovascular events over 18 years of follow-up: The Tehran Lipid and Glucose study
por: Koohi, Fatemeh, et al.
Publicado: (2021)

The Burden of Statin Therapy based on ACC/AHA and NCEP ATP-III Guidelines: An Iranian Survey of Non-Communicable Diseases Risk Factors
por: Asgari, Samaneh, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_7va1e0ip82tbafbvpu75oute7a